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Abstract
Background: To explore the role of microvascular pathology in migraine, we investigated the association between
migraine and retinal microvascular damage.
Methods: We included 3270 participants (age 45 years, 63% women) from the population-based Rotterdam Study
(2006–2009). Participants with migraine were identified using a validated questionnaire based on ICHD-II criteria
(n¼ 562). Retinopathy signs were graded on fundus photographs. Retinal arteriolar and venular caliber were measured
by semi-automatic assessment of fundus photographs. Associations of migraine with retinopathy and retinal microvascu-
lar calibers were examined using logistic and linear regression models, respectively, adjusting for age, sex, and cardio-
vascular risk factors.
Results: Migraine was not associated with the presence of retinopathy (odds ratio (OR): 1.09, 95% confidence interval
(CI) 0.62; 1.92). In the fully adjusted model, adjusting for the companion vessel, persons with migraine did not differ in
retinal arteriolar or venular caliber compared to persons without migraine (mean difference in standardized arteriolar
caliber 0.05 (95%CI 0.13; 0.03); in standardized venular caliber 0.00 (95%CI 0.09; 0.08)). Migraine subtypes,
including migraine with aura, were also not associated with retinal microvascular damage.
Conclusions: Our findings suggest that migraine is not associated with retinopathy or difference in retinal microvascular
caliber. Further studies are needed to confirm these results.
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Introduction
Migraine is a chronically recurring headache disorder
that aﬀects up to 14% of adults in Europe (1). Despite
the high individual and societal burden of migraine, the
exact pathogenesis remains elusive. Migraine has been
shown to have a substantial vascular component. It is
associated with an increased risk of cerebrovascular dis-
ease such as stroke (2–4) and markers of cerebrovascu-
lar damage such as white matter lesions (5). It has also
been identiﬁed as a risk factor for coronary heart
disease (2). Large vessel disease biomarkers such as ath-
erosclerosis are linked to cerebrovascular disease (6,7)
and have been extensively studied in migraine (8–10),
but have not yet elucidated common mechanisms.
Increasing evidence shows that microvascular path-
ology also contributes to stroke and coronary heart
disease (11,12). In parallel, microvascular damage has
also been implicated in the development of migraine
(13) and may provide an important insight into mech-
anisms of migraine. Microvascular damage visible on
retinal vascular imaging, including retinal vessel
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diameter and retinopathy signs, has been demonstrated
as a useful marker for studying the microcirculation
in cerebrovascular diseases (14). However, only a few
studies have examined the link between migraine and
retinal markers of microvascular damage (15,16),
and the nature of the association remains uncertain.
Therefore, in a large population-based cohort study,
we investigated the status of the retinal microvascular
circulation, as represented by retinopathy signs and ret-
inal vessel diameter, in persons with migraine.
Methods
Settings and study population
This study was based in the Rotterdam Study, a
prospective population-based cohort among the
middle-aged and elderly inhabitants of the district of
Ommoord in Rotterdam, The Netherlands (17). We
included participants from the third cohort (RS-III)
initiated in 2006 (n¼ 3892). Participants were assessed
by home interview and physical examination and exten-
sive examination at the research facility from 2006 to
2009. Time between migraine assessment and retinal
imaging averaged 6.4 weeks (standard deviation 9.6).
All participants who provided information on
migraine in the questionnaire (n¼ 3892) and had data
from retinal imaging were included in the current study.
Exclusion criteria were: Persons classiﬁed as ‘‘probable
migraine’’ (fulﬁlling all but one of the migraine
criteria (n¼ 177)); persons missing data on retinopathy
(n¼ 445); persons missing data on retinal vessel diam-
eter (n¼ 326). The population for analysis included
participants with data on migraine and retinopathy
(n¼ 3270, age range 45–89 years) and data on migraine
and retinal vessel diameter (n¼ 2944, age range 45–89
years)) (Supplementary Figure 1).
The Rotterdam Study has been approved by the
Medical Ethics Committee of the Erasmus MC accord-
ing to the Population Studies Act: Rotterdam Study.
All participants provided written informed consent.
Assessment of migraine
Migraine was assessed at the home interview through
administration of the migraine questionnaire by trained
interviewers; 634 participants completed the question-
naire by phone interview. The migraine questionnaire
was based on the migraine headache criteria from the
International Classiﬁcation of Headache Disorders,
second edition (ICHD-II) (18), and was modiﬁed from
the questionnaire validated for use in the Genetic
Epidemiology of Migraine (GEM) study in Leiden
(19). This questionnaire had a speciﬁcity of 0.93 and a
sensitivity of 0.36. The migraine questionnaire assessed
lifetime occurrence of headache attacks that fulﬁlled the
diagnostic criteria of more than ﬁve headache attacks,
with a duration of 4–72 hours (when untreated), with
typical migraine headache characteristics, and accom-
panying symptoms of photophobia or nausea.
As described previously (20), the migraine headache
criteria in our questionnaire diﬀered moderately from
the ICHD-II criteria: We asked participants if they had
ever experienced headache with severe pain, aﬀecting
their activities, instead of moderate to severe pain inten-
sity. In addition, migraine with aura was classiﬁed as at
least ﬁve (instead of two) headaches fulﬁlling all
migraine headache criteria in combination with head-
ache accompanied by aura symptoms lasting between
ﬁve to 60 minutes (20). All individuals who met the
criteria (20) for any lifetime history of migraine, includ-
ing migraine with and without aura, were classiﬁed
as persons with migraine. Persons with migraine were
also dichotomized into active migraine (<1 year
since last attack) or non-active migraine (>1 year
since last attack).
Assessment of retinopathy and retinal
microvascular calibers
Retinopathy and retinal microvascular calibers were
assessed in RS-III as a part of a full eye examination
in the research center, including self-reported ophthal-
mic history and simultaneous stereoscopic fundus
color photography of the optic disc (20 ﬁeld, Topcon
Optical Company, Tokyo, Japan) after pharmaco-
logical mydriasis (21).
Retinopathy signs were graded on fundus photo-
graphs of both eyes by two trained research physicians.
Retinopathy was deﬁned as the presence of soft or hard
exudates, micro-aneurysms, macular edema, cotton
wool spots, dot, blot or ﬂame shaped hemorrhages,
artery or vein branch occlusion, and laser coagulation
scars (21). For intra-rater and inter-rater agreement
(n¼ 113), fundus photographs were checked for quality
and the presence of retinopathy signs by two experi-
enced graders. These graders, each having 20 years
of experience, divided their work and graded all
fundus photographs particularly focusing on retinop-
athy signs. Consensus sessions and between-grader
comparisons were performed regularly, and weighted
k coeﬃcients ranged from 0.52 to 0.96 for various ret-
inopathy signs.
For retinal microvascular calibers, per participant
the fundus photograph of one eye with the best quality
was analyzed using the Retinal Vessel Measurement
System (Retinal Analysis, Optimate, WI; Department
of Ophthalmology and Visual Science, University of
Wisconsin-Madison) (23), and a separate summary
value was calculated for the arteriolar and venular
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calibers (in mm) after correction for diﬀerences in mag-
niﬁcation due to the refractive status of the eye (24–26).
We veriﬁed, in a random subsample of 100 participants,
that individual measurements in the left and right eye
were similar. Measurements were performed by two
raters blinded to participant characteristics. For inter-
rater and intrarater agreement (n¼ 100) the Pearson’s
correlation coeﬃcients were 0.85 and 0.86 for arteriolar
calibers, and 0.87 and 0.87 for venular calibers, respect-
ively (27). Persons who did not undergo ophthalmic
examination, or had fundus images on both eyes that
could not be graded, were excluded.
Covariates
Covariates were selected as cardiovascular and life-
style factors that may confound the association between
migraine and retinal microvascular damage. Education
was assessed at study entry and categorized into low
(primary education only), intermediate (secondary edu-
cation) and high (higher vocational education or univer-
sity) education level. Assessment of cardiovascular risk
factors (systolic blood pressure, diastolic blood pres-
sure, total cholesterol, high-density lipoprotein choles-
terol, use of antihypertensive medication indicated for
hypertension, use of lipid-lowering medication, diabetes
mellitus and smoking) has been described previously
(28). C-reactive protein was measured in nonfasting
frozen serum samples using Rate Near Infrared
Particle Immunoassay (Immage Immunochemistry
System, Beckman Coulter, Fullerton, CA). The pres-
ence of atherosclerotic plaques was assessed by ultra-
sound at the carotid artery bifurcation, common
carotid artery, and internal carotid artery on both
sides. Missing values for all covariates were imputed
using multiple imputation based on all variables in the
full regression model. All missing values were less than
5%. The percentage of missing values for each covariate
are described in Supplementary Table 1.
Statistical analysis
Diﬀerences in characteristics between groups were
tested by ANCOVA for continuous outcomes and
logistic regression for categorical outcomes, adjusted
for age and sex. Associations of migraine with retinop-
athy and retinal microvascular calibers were modeled
using logistic and linear regression models, respectively,
with persons without migraine as the reference group.
The covariate C-reactive protein was log-transformed
because of its skewed distribution. For analyses on ret-
inopathy, two models were constructed. The ﬁrst model
adjusted for age and sex, and the second model add-
itionally adjusted for education level, smoking, systolic
and diastolic blood pressure, C-reactive protein, total
cholesterol, high-density lipoprotein cholesterol, lipid-
lowering or antihypertensive medication use, the pres-
ence of atherosclerotic plaque and diabetes mellitus.
For analyses on retinal microvascular caliber, values
for retinal microvascular caliber were standardized by
calculating z-scores, and three models were con-
structed. The ﬁrst adjusted for age and sex, and the
second model additionally adjusted for the caliber of
the other vessel; the third model additionally adjusted
for education level, smoking, systolic and diastolic
blood pressure, C-reactive protein, total cholesterol,
high-density lipoprotein cholesterol, lipid-lowering or
antihypertensive medication use, the presence of ath-
erosclerotic plaque and diabetes mellitus. Arterial and
venular calibers are highly correlated and are associated
with clinical outcomes in opposite directions (29). This
may lead to confounding when the calibers are modeled
alone. Therefore, adjusting the model for the caliber of
the accompanying (other) vessel allows for correction
of this potential confounder. We also investigated ret-
inopathy and retinal microvascular caliber in migraine
subtypes, including migraine with aura and active
migraine. The potential interaction of migraine with
age and sex on retinopathy or microvascular caliber
was assessed by inclusion of interaction terms in the
regression models and by stratiﬁed analyses. Results
for retinopathy are presented as odds ratios (OR)
with 95% conﬁdence intervals (CI). Results for retinal
microvascular calibers are presented as betas that cor-
respond to mean diﬀerence in standardized arteriolar or
venular caliber with 95% CI. Statistical signiﬁcance
was considered to be two-sided p-values <0.05. No
adjustment was made for multiple testing due to the
exploratory nature of the study. All statistical analyses
were performed using the statistical software package
SPSS (IBM Corp., Armonk, New York, USA), version
21.0 for Windows.
Results
Table 1 presents the descriptives of the study popula-
tion. In all, 562 persons were classiﬁed as persons with
deﬁnite migraine, of which 126 participants had
migraine with aura and 307 had active migraine.
Persons with migraine were younger than those without
migraine and a higher percentage were women (Table 1).
After adjusting for age and sex, a lower percentage of
persons with migraine were current smokers, while a
higher percentage were former smokers and used lipid-
lowering medication.
Amongst persons without migraine, 3.3% had retin-
opathy while amongst persons with migraine 2.8% had
retinopathy (Table 1). After multivariate adjustment,
persons with migraine were not more likely to have
retinopathy (OR 1.09, 95% CI 0.62; 1.92) compared
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Table 1. Descriptives of the study population (n¼ 3270).
No migraine
(n¼ 2708)
Definite
migraine (n¼ 562) p-value
Age (years) 57.0 (6.8) 56.1 (6.3) 0.006*
Female 1383 (51.1%) 449 (79.9%) <0.001*
Education level
Low 737 (27.2%) 158 (28.1%) 0.38
Intermediate 1240 (45.8%) 253 (45.0%) 0.66
High 731 (27.0%) 151 (26.9%) 0.13
Smoking
Never 789 (29.1%) 186 (33.1%) 0.91
Current 765 (28.2%) 116 (20.6%) 0.003*
Former 1154 (42.6%) 260 (46.3%) 0.012*
Systolic blood pressure (mmHg) 133.0 (19.3) 131.1 (18.9) 0.80
Diastolic blood pressure (mmHg) 82.5 (11.1) 82.8 (10.9) 0.14
C-reactive protein (mg/L) (log-transformed) 0.12 (0.5) 0.13 (0.5) 0.64
Total cholesterol (mmol/L) 5.5 (1.1) 5.7 (1.1) 0.52
High-density lipoprotein cholesterol (mmol/L) 1.4 (0.4) 1.5 (0.4) 0.17
Lipid-lowering medication use 600 (22.2%) 135 (24.0%) 0.010*
Antihypertensive use 627 (23.2%) 139 (24.7%) 0.07
Atherosclerotic plaque (yes) 979 (36.2%) 178 (31.7%) 0.65
Diabetes mellitus (yes) 275 (10.2%) 48 (8.5%) 0.94
Retinopathy (yes) 90 (3.3%) 16 (2.8%)
Mean arteriolar caliber (mm) 158.5 (15.6) 157.3 (15.6)
Mean venular caliber (mm) 239.7 (23.0) 238.0 (22.9)
Migraine with aura NA 126 (22.4%)
Values are presented as mean (standard deviation) or count (percentages). n¼ number of persons. Reported values are
obtained from the first imputed dataset. Percentage of missing values imputed for each covariate are described in
Supplementary Table 1 (S1). Differences in characteristics between groups were tested by ANCOVA for continuous
outcomes and logistic regression for categorical outcomes, adjusted for age and sex. Difference compared to persons
without migraine: *p< 0.05.
Table 2. Retinopathy in persons with migraine compared to persons without migraine.
n: N Model 1 p-value Model 2 p-value
No migraine 90: 2618 1.00 (reference) 1.00 (reference)
Migraine 16: 546 0.99 (0.57; 1.73) 0.98 1.09 (0.62; 1.92) 0.77
Migraine with aura 5: 121 1.40 (0.55; 3.56) 0.48 1.65 (0.63; 4.30) 0.31
Migraine without aura 11: 425 0.87 (0.46; 1.67) 0.68 0.96 (0.50; 1.85) 0.90
Active migraine 9: 298 1.11 (0.54; 2.27) 0.78 1.31 (0.63; 2.72) 0.47
Non-active migraine 7: 248 0.86 (0.39; 1.90) 0.71 0.90 (0.40; 2.01) 0.79
Values given are odds ratios and 95% CI (from logistic regression) in persons with migraine and migraine subtypes for
retinopathy, compared to persons without migraine. n¼ number of persons with retinopathy; N¼ number of persons
without retinopathy. Model 1: adjusted for age and sex. Model 2: additionally adjusted for education level, smoking,
systolic and diastolic blood pressure, C-reactive protein, total cholesterol, high-density lipoprotein cholesterol, lipid-
lowering or antihypertensive medication use, presence of atherosclerotic plaque and diabetes mellitus. Difference
compared to persons without migraine: *p< 0.05.
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to persons without migraine (Table 2). Migraine sub-
types, including migraine with aura, were not associated
with a higher prevalence of retinopathy (Table 2).
The presence of migraine was associated with a
lower arteriolar caliber in the age and sex adjusted
model (0.10, 95% CI 0.20; 0.01); the diﬀerence
in venular caliber was in the same direction, but
non-signiﬁcant (0.06, 95% CI 0.16; 0.04)
(Table 3). However, these diﬀerences were attenuated
in both arteriolar and venular caliber after adjustment
for the other vessel and further adjustment for cardio-
vascular risk factors. Analyses of migraine subtypes
did not demonstrate any diﬀerence in the estimates
(Table 3).
Table 3. Adjusted mean difference in retinal microvascular caliber between persons with and without migraine.
Number Model 1 p-value Model 2 p-value Model 3 p-value
Arterioles
No migraine 2439 0.00 (reference) 0.00 (reference) 0.00 (reference)
Migraine 505 0.10 (0.20; 0.01) 0.039* 0.07 (0.15; 0.01) 0.10 0.05 (0.13; 0.03) 0.20
Migraine with aura 112 0.15 (0.34; 0.03) 0.11 0.10 (0.26; 0.06) 0.21 0.10 (0.25; 0.05) 0.18
Migraine without aura 393 0.09 (0.20; 0.02) 0.09 0.06 (0.16; 0.03) 0.16 0.04 (0.12; 0.05) 0.40
Active migraine 277 0.08 (0.20; 0.05) 0.23 0.04 (0.14; 0.07) 0.51 0.05 (0.15; 0.05) 0.34
Non-active migraine 228 0.14 (0.27; 0.01) 0.040* 0.12 (0.23; 0.01) 0.039* 0.06 (0.17; 0.05) 0.29
Venules
No migraine 2439 0.00 (reference) 0.00 (reference) 0.00 (reference)
Migraine 505 0.06 (0.16; 0.04) 0.22 0.01 (0.09; 0.08) 0.85 0.00 (0.09; 0.08) 0.92
Migraine with aura 112 0.10 (0.29; 0.09) 0.30 0.02 (0.18; 0.14) 0.80 0.01 (0.17; 0.15) 0.92
Migraine without aura 393 0.05 (0.16; 0.06) 0.34 0.00 (0.10; 0.09) 0.92 0.00 (0.09; 0.09) 0.92
Active migraine 277 0.08 (0.21; 0.05) 0.21 0.04 (0.15; 0.07) 0.46 0.02 (0.12; 0.09) 0.76
Non-active migraine 228 0.04 (0.18; 0.10) 0.57 0.04 (-0.08; 0.15) 0.56 0.01 (0.10; 0.12) 0.85
Values given are mean difference and 95% confidence intervals (from linear regression) in standardized arteriolar and venular calibers of persons with
migraine compared to persons without migraine. Model 1: age and sex adjusted. Model 2: additionally adjusted for the other retinal vessel. Model 3:
additionally adjusted for education level, smoking, systolic and diastolic blood pressure, C-reactive protein, total cholesterol, high-density lipoprotein
cholesterol, lipid-lowering or antihypertensive medication use, presence of atherosclerotic plaque and diabetes mellitus. Different compared to persons
without migraine: *p< 0.05.
Table 4. Retinopathy and retinal microvascular caliber in persons with migraine compared to persons without migraine, stratified on
age and sex.
n/N Retinopathy p-value n/N Arteriolar caliber p-value Venular caliber p-value
OR (95% CI) Mean difference (95% CI) Mean difference (95% CI)
Age 65 529/2487 0.91 (0.50; 1.68) 0.77 478/2259 0.03 (0.11; 0.05) 0.41 0.00 (0.09; 0.08) 0.09
Age> 65 33/221 0.59 (0.11; 3.31) 0.55 27/180 0.29 (0.59; 0.02) 0.07 0.06 (0.38; 0.26) 0.72
p-interaction 0.99 0.59 0.23
Men 113/1325 0.79 (0.30; 2.09) 0.64 98/1168 0.15 (0.10; 0.31) 0.07 0.04 (0.21; 0.13) 0.64
Women 449/1383 1.00 (0.49; 2.01) 0.99 407/1271 0.11(0.20; 0.02) 0.015* 0.00 (0.10; 0.09) 0.96
p-interaction 0.78 0.005 0.58
Values given for retinopathy are odds ratios and 95% confidence intervals (from logistic regression) in persons with migraine for retinopathy compared
to persons without migraine. Values given for arterioles and venules are mean difference and 95% confidence intervals (from linear regression) of
standardized arteriolar and venular calibers of persons with migraine compared to persons without migraine. All estimates were obtained from the
model adjusted for age, sex, education level, smoking, systolic and diastolic blood pressure, C-reactive protein, total cholesterol, high-density lipo-
protein cholesterol, lipid-lowering or antihypertensive medication use, presence of atherosclerotic plaque and diabetes mellitus; the model for
arteriolar and venular caliber was additionally adjusted for the other vessel caliber. n¼ number of persons with migraine, N¼ number of persons
without migraine. Different compared to persons without migraine: *p< 0.05.
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When investigating interaction eﬀects, no signiﬁcant
interaction of migraine with age or sex on the associ-
ation of migraine with retinopathy was found (Table 4).
There was also no interaction of migraine with age
in the association with the arteriolar or venular
calibers. However, there was interaction between
migraine and sex on arteriolar caliber (p-value for inter-
action¼ 0.005). Speciﬁcally, mean arteriolar caliber
was narrower in women with migraine compared to
women without migraine (0.11, 95% CI 0.20;
0.02), whereas in men with migraine the mean diﬀer-
ence in arteriolar caliber compared to men without
migraine was in the opposite direction (0.15, 95% CI
0.10; 0.31). No migraine-sex interaction was found on
venular caliber (p-value for interaction¼ 0.58).
Discussion
In this population-based cohort study, we found that
lifetime migraine was not associated with markers of
retinal microvascular damage. Importantly, migraine
was not associated with either subclinical markers or
clinical retinal microvascular damage, as shown by ret-
inal vessel caliber and retinopathy, respectively.
Findings from previous studies on these associations
have been equivocal. One previous study, reporting
increased presence of retinopathy in persons with
migraine (16), had a higher prevalence of retinopathy
of around 7.7% for persons with migraine without aura
compared to 2.8% for all persons with migraine in our
study population, despite a comparable age range.
Retinopathy could be underestimated in our study
population as the use of only fundus photographs cen-
tered on the macula excludes damage visible in other
retinal ﬁelds. This may partially underlie the diﬀerent
ﬁndings. Additionally, persons with migraine or other
headaches were found to have smaller mean arteriolar
caliber (15,16) and venular caliber than those without
migraine (16). These studies had mixed results for
migraine subtypes: Persons with migraine with aura
were found to have smaller arteriolar and venular cali-
ber (16), while the other study found only persons with
migraine without aura had smaller arteriolar caliber
(15). Notably, we found similar estimates to previous
studies when modeling the retinal vessel calibers separ-
ately, whereas the diﬀerences became non-signiﬁcant
after modeling the arteriolar and venular caliber
simultaneously. The retinal vessel calibers are highly
correlated, but are associated in opposite directions
with cardiovascular disease (29). Therefore, simultan-
eous modeling of both retinal vessels ensured adjust-
ment for confounding by this correlation, which could
have inﬂuenced the previous ﬁndings.
The reported associations between microvascular
damage and increased risk of hypertension, coronary
atherosclerosis and coronary heart disease (12,30–33)
may provide further indications regarding the mechan-
isms of a potential association between migraine and
cardiovascular disease (2,3). Migraine has also been
associated with microvascular pathology in the brain
in the form of cerebral microbleeds (13). However, we
were unable to identify a link between migraine and
extracerebral microvascular damage. One explanation
may be that our study population was much younger
than the population investigated for microbleeds, and
thus may have a lower load of microvascular damage.
Furthermore, migraine may not be unequivocally asso-
ciated with vascular pathology traditionally linked to
cardiovascular disease. Persons with migraine in our
study had a comparable cardiovascular risk proﬁle to
persons without migraine, supporting this theory.
Persons with migraine have a shared genetic risk of
stroke (4), and stroke has been strongly linked
to changes in retinal microvasculature (34). However,
persons with migraine have a lower genetic risk of cor-
onary artery disease (35), and in these persons cerebral
perfusion may be increased interictally (20). The fact
that we did not ﬁnd an association between migraine
and retinal vessel damage indicates that the shared eti-
ology of migraine and stroke may not be explained by
well-established pathways such as atherosclerosis.
Alternatively, persons with severe migraine may be
non-participants in our study, and therefore the eﬀects
of chronic migraine could be underestimated. Analysis
of migraine subgroups indicated that persons with
active migraine were at a greater (non-signiﬁcant) risk
of retinopathy than those with non-active migraine,
suggesting that any risk of retinopathy due to migraine
may only be present in the active period. Similarly, the
association of migraine and stroke is strongest in young
women (36). However, our analysis of migraine sub-
groups may have been insuﬃciently powered to draw con-
clusions from. Finally, when we explored the eﬀects of age
and sex on the association between migraine and micro-
vascular markers, women with migraine appeared to have
narrower arterioles than women without migraine.
However, as the estimate amongst men was considerably
in the opposite direction (although non-signiﬁcant), eﬀect
modiﬁcation by sex may be a spurious ﬁnding.
Our study has a number of limitations. Firstly, the
migraine questionnaire used an adapted ICHD-II
migraine criteria (20), which could have misclassiﬁed
persons with moderate migraine headache but not
severe headache into the control group. Those with
migraine with aura could have been misclassiﬁed as
persons with migraine without aura due to limited
information on aura symptoms. This misclassiﬁcation
may have led to an underestimation of our eﬀects.
Furthermore, retinopathy may be underestimated,
as previously explained. Due to limited information,
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we were unable to adjust for potential confound-
ing eﬀects of pain medication use in our study.
Additionally, in subgroup analyses, the numbers in
each group may have been too small to obtain ade-
quate estimates. Finally, the cross-sectional design of
the study precludes causal interpretation of our ﬁnd-
ings. Strengths of this study include the large popula-
tion-based sample and use of both pre-clinical and
clinical markers of retinal microvascular damage.
Furthermore, adjustment of retinal microvascular
caliber by the other vessel caliber allowed for correc-
tion of confounding from the positive correlation of the
arteriolar and venular calibers (29).
In conclusion, we did not ﬁnd persons with migraine
or migraine with aura to be more likely to have retin-
opathy than persons without migraine, and there was
no diﬀerence in retinal arteriolar or venular caliber
between the two groups. More studies are needed to
corroborate the ﬁndings and understand the role of
microvascular pathology in migraine.
Public health relevance
. Persons with migraine do not appear to be at greater risk of retinopathy.
. Persons with migraine did not diﬀer in retinal microvascular damage compared to persons without migraine.
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